Invesco Ltd. Mirum Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 64,653 shares of MIRM stock, worth $4.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,653

Previous 313,423 79.37%

Holding current value

$4.18 Million

Previous $14.1 Million 76.7%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$38.39 - $51.11 $9.55 Million - $12.7 Million	-248,770 Reduced 79.37%	64,653 $3.29 Million
Q1 2025 May 12, 2025	BUY	$41.32 - $53.16 $584,430 - $751,895	14,144 Added 4.73%	313,423 $14.1 Million
Q4 2024 Feb 13, 2025	BUY	$37.85 - $46.65 $558,173 - $687,947	14,747 Added 5.18%	299,279 $12.4 Million
Q3 2024 Nov 12, 2024	BUY	$33.68 - $44.74 $16,402 - $21,788	487 Added 0.17%	284,532 $11.1 Million
Q2 2024 Aug 13, 2024	BUY	$23.57 - $34.85 $5.78 Million - $8.54 Million	245,024 Added 627.93%	284,045 $9.71 Million
Q1 2024 May 14, 2024	SELL	$24.92 - $30.02 $1.14 Million - $1.38 Million	-45,846 Reduced 54.02%	39,021 $980,000
Q4 2023 Feb 12, 2024	SELL	$27.14 - $34.93 $2.14 Million - $2.76 Million	-78,900 Reduced 48.18%	84,867 $2.51 Million
Q3 2023 Nov 13, 2023	BUY	$24.63 - $32.85 $3.16 Million - $4.22 Million	128,374 Added 362.71%	163,767 $5.18 Million
Q2 2023 Aug 11, 2023	SELL	$23.51 - $30.09 $121,852 - $155,956	-5,183 Reduced 12.77%	35,393 $915,000
Q1 2023 May 12, 2023	SELL	$19.19 - $24.1 $7,100 - $8,917	-370 Reduced 0.9%	40,576 $974,000
Q4 2022 Feb 13, 2023	BUY	$17.59 - $23.83 $148,899 - $201,720	8,465 Added 26.06%	40,946 $798,000
Q3 2022 Nov 14, 2022	SELL	$19.98 - $29.44 $4,415 - $6,506	-221 Reduced 0.68%	32,481 $682,000
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $37,042 - $55,302	2,011 Added 6.55%	32,702 $636,000
Q1 2022 May 16, 2022	SELL	$15.5 - $23.93 $264,523 - $408,389	-17,066 Reduced 35.74%	30,691 $675,000
Q4 2021 Feb 14, 2022	BUY	$13.05 - $19.35 $108,562 - $160,972	8,319 Added 21.09%	47,757 $762,000
Q3 2021 Nov 15, 2021	SELL	$13.95 - $20.18 $110,065 - $159,220	-7,890 Reduced 16.67%	39,438 $786,000
Q2 2021 Aug 17, 2021	BUY	$15.84 - $20.6 $29,430 - $38,274	1,858 Added 4.09%	47,328 $818,000
Q1 2021 May 17, 2021	BUY	$16.29 - $21.92 $8,226 - $11,069	505 Added 1.12%	45,470 $901,000
Q4 2020 Feb 16, 2021	BUY	$15.75 - $25.45 $144,002 - $232,689	9,143 Added 25.52%	44,965 $785,000
Q3 2020 Nov 16, 2020	BUY	$18.4 - $26.59 $659,124 - $952,506	35,822 New	35,822 $691,000

Others Institutions Holding MIRM

# of Institutions

229

Shares Held

56.1M

Call Options Held

25.3K

Put Options Held

98.9K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $2.38B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account